insights_auto
Kwa nini TNDM imepungua kwa 2.06%?
Fahamu zaidichevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
US$ 16.18
arrow_downward
-2.06%(-0.34) Siku 1
6 Okt, 15:59:42 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya TNDM...
Fungua
US$ 16.77
Juu
US$ 17.05
Chini
US$ 15.94
Mtaji wa soko
1.12B
Wastani wa kiasi cha mauzo
1.93M
Kiasi cha mauzo ya hisa
elfu 953.99
Juu kwa wiki 52
US$ 29.65
Chini kwa wiki 52
US$ 12.26
EPS
-US$ 0.93
Beta
1.66
Hisa za wawekezaji
69.58M
Idadi ya wafanyakazi
elfu 2
Fungua
US$ 16.77
Juu
US$ 17.05
Chini
US$ 15.94
Mtaji wa soko
1.12B
Wastani wa kiasi cha mauzo
1.93M
Kiasi cha mauzo ya hisa
elfu 953.99
Juu kwa wiki 52
US$ 29.65
Chini kwa wiki 52
US$ 12.26
EPS
-US$ 0.93
Beta
1.66
Hisa za wawekezaji
69.58M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
siku 1 iliyopita
Tandem Diabetes Care stock gains 2.36 percent before Q3 results
Wasifu
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Kuhusu Tandem Diabetes Care Inc
Afisa Mkuu Mtendaji (CEO)John Sheridan
Wafanyakazielfu 2.5
LilianzishwaJan 2006
Makao makuu-
Sekta-
Tovutitandemdiabetes.com